ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Tonix Medicines at ACR Convergence 2026

Nov 6–11, 2026 Orlando, FL ~15k attendees Website

Tonix Medicines brings 2 presentations to ACR Convergence 2026 in Orlando, and exhibits at Booth 1613. Its program centres on Tonmya, a sublingual cyclobenzaprine tablet for fibromyalgia. It covers pooled phase 3 results on the likelihood of benefit versus harm, and what the first FDA-approved fibromyalgia treatment in over 15 years means for adult patients.

OrganizationACR Convergence 2026 Attendance
Tonix Medicines
Berkeley Heights, NJ
Biotech companies
Commercial subsidiary of Tonix Pharmaceuticals with products for fibromyalgia and migraine.
Booth
Exhibiting at Booth 1613
Sun, Nov 810:00am–5:00pmMon, Nov 910:00am–5:00pmTue, Nov 1010:00am–2:30pm
Industry
Tue Nov 10
10:30am–11:15am
What the First FDA-Approved Treatment for Fibromyalgia in Over 15 Years Means for Your Adult Patients
Innovation Theater A
Pain and fibromyalgia · with Swedish Medical Center/Providence St. Joseph Health, Orthopedic Physicians of Alaska

Explore the full ACR Convergence 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Orlando. Leave your work email and we’ll be in touch.

Privacy

Download the full ACR Convergence 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Tonix Medicines

Tell us what you sell and we’ll find the people at Tonix Medicines most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction